Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells
Li Ma,1 Xinyu Cao,2 Xiaotong Ye,2 Jianping Ye,2 Yongning Sun1,3 1Department of Traditional Chinese Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, People’s Republic of China; 2Shanghai Diabetes Institute, Shanghai Jiao Tong University...
Enregistré dans:
Auteurs principaux: | Ma L, Cao X, Ye X, Ye J, Sun Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fe5bc8eadbe14807b451beed844f55b9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Simultaneous Effect of Resveratrol and Probiotics on Insulin Resistance and Glucagon-Like Peptide (GLP-1) Levels in Diabetic Rats
par: A Pegah, et autres
Publié: (2021) -
Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
par: Orme ME, et autres
Publié: (2017) -
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
par: Knop FK, et autres
Publié: (2010) -
The associations of incretin hormone concentration with gestational diabetes mellitus
par: Tatiana V. Saprina, et autres
Publié: (2016) -
The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
par: Marina Vladimirovna Shestakova
Publié: (2010)